EGR1 and acute myeloid leukemia: Egr1+/−mice develop AML or an MPD-like leukemia with a shorter latency and at a higher overall frequency than WT littermate controls (median survival: Egr1 WT 456 days, Egr1 +/− 397 days, p=0.038) (Figure 3).